Aleksej V. Klemenov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aleksej V. Klemenov has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Aleksey Viktorovich Klemenov
City Clinical Hospital № 30
1 shared publicationButusov M.V. Butusov
1 shared publicationDmitrij V. Pikulev
Municipal Clinical Hospital no. 30
1 shared publication- K.V. Kuchin1 shared publication
- Kuchin K.V. Kuchin
Clinic Hospital Number 38, 22 Chernyshevsky st., 603000 Nizhny Novgorod, Russia
1 shared publication - M.V. Butusov1 shared publication
Latest Publications
- 16 October 2025
- Published by Bionika Media in Therapy
- Vol. 7_2025
Phenotyping of patients with arterial hypertension based on the renal filtration function and arterial stiffness using cluster analysis
- 16 October 2025
- Published by Bionika Media in Therapy
- Vol. 7_2025
Phenotyping of patients with arterial hypertension based on the renal filtration function and arterial stiffness using cluster analysis
- Open Access
- 24 May 2024
- Published by National Medical Research Center For Rehabilitation And Balneology in Bulletin of Rehabilitation Medicine
- Vol. 23 (2)
Possibilities of backward walking application in the rehabilitation of patients with gonarthrosis: review
INTRODUCTION. Osteoarthritis of the knee joint or gonarthrosis (GA) is one of the most common joint pathologies. The medical and social significance of GA is associated with its high prevalence and a significant percentage of premature disability and a significant deterioration in the quality of life due to persistent pain syndrome. Modern treatment of patients with GA includes a combination of pharmacological and non-pharmacological methods; physical therapy is the leading method of non-drug therapy. By now, a number of studies have been conducted to research the effectiveness of backward walking (BW) in people with GA. AIM. Analysis of scientific data on the possibilities of using BW in the rehabilitation of patients with GA. MATERIALS AND METHODS. A systematic search of literary sources by keywords was carried out: “backward walking”, “gonarthrosis”, “knee osteoarthritis”, “knee joint”, “rehabilitation”, “physical therapy”. DISCUSSION. Recently, backward locomotion is increasingly used in medicine. Kinetic and kinematic analysis during BW showed a number of advantages over the usual method of movement, which can be successfully used for rehabilitation of patients with GA. BW is associated with less overload on knee joints. It is also one of the few natural ways of strengthening the quadriceps. It prevents excessive stretching of the anterior cruciate ligament and improves the stability of the knee joint. BW leads to a more cardiovascular and respiratory load and a more significant aerobic and anaerobic capacity of the organism compared with forward walking at similar parameters of physical activity. CONCLUSION. There is evidence that adding BW to conventional physiotherapy treatment may further reduce pain, functional disability and improve the strength of the quadriceps muscles.
- 24 May 2024
- Published by National Medical Research Center For Rehabilitation And Balneology in Bulletin of Rehabilitation Medicine
- Vol. 23 (2)
Open AccessPossibilities of backward walking application in the rehabilitation of patients with gonarthrosis: review
INTRODUCTION. Osteoarthritis of the knee joint or gonarthrosis (GA) is one of the most common joint pathologies. The medical and social significance of GA is associated with its high prevalence and a significant percentage of premature disability and a significant deterioration in the quality of life due to persistent pain syndrome. Modern treatment of patients with GA includes a combination of pharmacological and non-pharmacological methods; physical therapy is the leading method of non-drug therapy. By now, a number of studies have been conducted to research the effectiveness of backward walking (BW) in people with GA. AIM. Analysis of scientific data on the possibilities of using BW in the rehabilitation of patients with GA. MATERIALS AND METHODS. A systematic search of literary sources by keywords was carried out: “backward walking”, “gonarthrosis”, “knee osteoarthritis”, “knee joint”, “rehabilitation”, “physical therapy”. DISCUSSION. Recently, backward locomotion is increasingly used in medicine. Kinetic and kinematic analysis during BW showed a number of advantages over the usual method of movement, which can be successfully used for rehabilitation of patients with GA. BW is associated with less overload on knee joints. It is also one of the few natural ways of strengthening the quadriceps. It prevents excessive stretching of the anterior cruciate ligament and improves the stability of the knee joint. BW leads to a more cardiovascular and respiratory load and a more significant aerobic and anaerobic capacity of the organism compared with forward walking at similar parameters of physical activity. CONCLUSION. There is evidence that adding BW to conventional physiotherapy treatment may further reduce pain, functional disability and improve the strength of the quadriceps muscles.
- Open Access
- 15 January 2024
- Published by Publishing House ABV Press in The Clinician
- Vol. 18 (1) , 31-36
Alcoholic cardiomyopathy: aspects of pathogenesis and clinic
Alcoholic cardiomyopathy is the most common form of myocardial damage caused by ethanol. Ethanol and its main active metabolite acetaldehyde have a direct toxic effect on the myocardium. The mechanisms of the cardiotoxic effect of ethanol are diverse and include membranotropic action, damage to cellular organelles, activation of lipid peroxidation, and a number of others. Dissolving in the lipids of biological membranes, ethanol changes their physico-chemical properties, disrupts the activity of membrane receptors, eventually disconnecting the connection of excitation with the contraction of cardiomyocytes. Particular importance in the pathogenesis of alcoholic cardiomyopathy is attached to the ability of ethanol to cause structural and functional changes in mitochondria, which is directly related to the violation of oxidative processes and energy supply of the myocardium as a whole. Under the influence of alcohol, free-radical lipid oxidation products content increases and antioxidants activity decreases, which indicates oxidative stress development. The deterioration of myocardial contractility due to chronic alcohol intoxication triggers a cascade of compensatory mechanisms in the form of cardiomyocyte hypertrophy and progressive fibrosis, while adaptive reactions become a factor in further pathological changes. Ethanol causes myocardial damage in a dose-dependent manner.The probability of alcoholic cardiomyopathy occurrence is a derivative of the total accumulated dose of alcohol and individual predisposition. Alcoholic cardiomyopathy is considered as a variant of secondary dilated cardiomyopathy with all its clinical manifestations and consequences: dilation of the heart chambers, low left ventricular ejection fraction, progressive circulatory insufficiency, and cardiac arrhythmias. A relatively favorable prognosis in alcoholic cardiomyopathy is provided due to partial reversibility of myocardial damage under the condition of abstinence from alcohol consumption. Specific drugs for the treatment of alcoholic cardiomyopathy have not been developed. New treatment strategies include the use of myocardial growth and regulation factors synthesized by cardiomyocytes, as well as the stimulation of heart muscle regeneration and repair processes.
- 15 January 2024
- Published by Publishing House ABV Press in The Clinician
- Vol. 18 (1) , 31-36
Open AccessAlcoholic cardiomyopathy: aspects of pathogenesis and clinic
Alcoholic cardiomyopathy is the most common form of myocardial damage caused by ethanol. Ethanol and its main active metabolite acetaldehyde have a direct toxic effect on the myocardium. The mechanisms of the cardiotoxic effect of ethanol are diverse and include membranotropic action, damage to cellular organelles, activation of lipid peroxidation, and a number of others. Dissolving in the lipids of biological membranes, ethanol changes their physico-chemical properties, disrupts the activity of membrane receptors, eventually disconnecting the connection of excitation with the contraction of cardiomyocytes. Particular importance in the pathogenesis of alcoholic cardiomyopathy is attached to the ability of ethanol to cause structural and functional changes in mitochondria, which is directly related to the violation of oxidative processes and energy supply of the myocardium as a whole. Under the influence of alcohol, free-radical lipid oxidation products content increases and antioxidants activity decreases, which indicates oxidative stress development. The deterioration of myocardial contractility due to chronic alcohol intoxication triggers a cascade of compensatory mechanisms in the form of cardiomyocyte hypertrophy and progressive fibrosis, while adaptive reactions become a factor in further pathological changes. Ethanol causes myocardial damage in a dose-dependent manner.The probability of alcoholic cardiomyopathy occurrence is a derivative of the total accumulated dose of alcohol and individual predisposition. Alcoholic cardiomyopathy is considered as a variant of secondary dilated cardiomyopathy with all its clinical manifestations and consequences: dilation of the heart chambers, low left ventricular ejection fraction, progressive circulatory insufficiency, and cardiac arrhythmias. A relatively favorable prognosis in alcoholic cardiomyopathy is provided due to partial reversibility of myocardial damage under the condition of abstinence from alcohol consumption. Specific drugs for the treatment of alcoholic cardiomyopathy have not been developed. New treatment strategies include the use of myocardial growth and regulation factors synthesized by cardiomyocytes, as well as the stimulation of heart muscle regeneration and repair processes.
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Cardiology: News, Opinions, Training
- Vol. 12 (4)
Clinical features of patients with arterial hypertension depending on the state of renal filtration function and arterial stiffness
Клинические особенности пациентов с артериальной гипертензией в зависимости от состояния фильтрационной функции почек и артериальной жесткости
- 1 January 2024
- Published by Geotar-Media Publishing Group in Cardiology: News, Opinions, Training
- Vol. 12 (4)
Open AccessClinical features of patients with arterial hypertension depending on the state of renal filtration function and arterial stiffness
Клинические особенности пациентов с артериальной гипертензией в зависимости от состояния фильтрационной функции почек и артериальной жесткости
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Cardiology: News, Opinions, Training
- Vol. 12 (1)
Alcoholic cardiomyopathy: literature review
Алкогольная кардиомиопатия: обзор литературы
- 1 January 2024
- Published by Geotar-Media Publishing Group in Cardiology: News, Opinions, Training
- Vol. 12 (1)
Open AccessAlcoholic cardiomyopathy: literature review
Алкогольная кардиомиопатия: обзор литературы
- 7 January 2023
- Published by Open Systems Publications in Лечащий врач
- No. 1(26)
Allergic diseases and pregnancy
Allergic reactions are quite common in pregnant women. The most common manifestations of an allergic reaction during pregnancy are: from the respiratory tract – allergic rhinitis and bronchial asthma, from the skin and subcutaneous tissue (allergodermatosis) – urticaria, angioedema, atopic dermatitis. As a rule, allergies do not affect the course of pregnancy, and pregnancy does not affect the allergic process, however, allergic reactions in pregnant women can cause difficulties associated with the selection of pharmaceuticals. The article discusses practical issues of pregnant women with allergic diseasesmanagement. Attention is paid to the place of non-drug methods: hypoallergenic diet and enterosorbents for food allergies, the use of sprays based on saline solutions for allergic rhinitis. Medication management of pregnant women suffering from allergic diseases is a compromise between the potential adverse effect of medications on the fetus and the course of pregnancy and the consequences of uncontrolled allergy. If it is necessary to prescribe antihistamines in the second-third trimesters, it should be assumed that category B according to the FDA classification («no evidence of risk») includes chlorpheniramine, ciproheptadine (Peritol), diphenhydramine (Dimedrol), chlorotripelenamine (Suprastin), cetirizine (Zirtek, Cetrin), loratadine (Claritin), levocetirizine (Xizal). It is contraindicated to take astemizole, terfenadine, Tavegil (klemastin) because of the teratogenic or fetotoxic effect, desloratadine and ketotifen due to their ability to penetrate the placenta. Glucocorticosteroids are the drugs of choice in the treatment of severe forms of allergic diseases in pregnant women. Nasal corticosteroids are widely used in the treatment of moderate and severe allergic rhinitis. Inhaled glucocorticosteroids occupy a central place as a basic means for bronchial asthma. The drug of choice is budesonide, which has the best safety profile and has the greatest evidence base. Topical glucocorticosteroids (Advantan, Locoid, Elokom) in the form of creams and ointments are widely used in atopic dermatitis in pregnant women. If it is necessary to prescribe oral glucocorticosteroids (generalized urticaria, angioedema, severe exacerbation of atopic dermatitis), prednisone is preferred. Deposited glucocorticosteroids are categorically contraindicated. The use of cromoglycic acid, monoclonal antibodies, decongestants, bronchodilators is also discussed.
- 7 January 2023
- Published by Open Systems Publications in Лечащий врач
- No. 1(26)
Allergic diseases and pregnancy
Allergic reactions are quite common in pregnant women. The most common manifestations of an allergic reaction during pregnancy are: from the respiratory tract – allergic rhinitis and bronchial asthma, from the skin and subcutaneous tissue (allergodermatosis) – urticaria, angioedema, atopic dermatitis. As a rule, allergies do not affect the course of pregnancy, and pregnancy does not affect the allergic process, however, allergic reactions in pregnant women can cause difficulties associated with the selection of pharmaceuticals. The article discusses practical issues of pregnant women with allergic diseasesmanagement. Attention is paid to the place of non-drug methods: hypoallergenic diet and enterosorbents for food allergies, the use of sprays based on saline solutions for allergic rhinitis. Medication management of pregnant women suffering from allergic diseases is a compromise between the potential adverse effect of medications on the fetus and the course of pregnancy and the consequences of uncontrolled allergy. If it is necessary to prescribe antihistamines in the second-third trimesters, it should be assumed that category B according to the FDA classification («no evidence of risk») includes chlorpheniramine, ciproheptadine (Peritol), diphenhydramine (Dimedrol), chlorotripelenamine (Suprastin), cetirizine (Zirtek, Cetrin), loratadine (Claritin), levocetirizine (Xizal). It is contraindicated to take astemizole, terfenadine, Tavegil (klemastin) because of the teratogenic or fetotoxic effect, desloratadine and ketotifen due to their ability to penetrate the placenta. Glucocorticosteroids are the drugs of choice in the treatment of severe forms of allergic diseases in pregnant women. Nasal corticosteroids are widely used in the treatment of moderate and severe allergic rhinitis. Inhaled glucocorticosteroids occupy a central place as a basic means for bronchial asthma. The drug of choice is budesonide, which has the best safety profile and has the greatest evidence base. Topical glucocorticosteroids (Advantan, Locoid, Elokom) in the form of creams and ointments are widely used in atopic dermatitis in pregnant women. If it is necessary to prescribe oral glucocorticosteroids (generalized urticaria, angioedema, severe exacerbation of atopic dermatitis), prednisone is preferred. Deposited glucocorticosteroids are categorically contraindicated. The use of cromoglycic acid, monoclonal antibodies, decongestants, bronchodilators is also discussed.
- 12 December 2022
- Published by Bionika Media in Therapy
- Vol. 9_2022
Management of patients with allergic diseases during pregnancy
- 12 December 2022
- Published by Bionika Media in Therapy
- Vol. 9_2022
Management of patients with allergic diseases during pregnancy
- 9 April 2021
- Published by Bionika Media in Therapy
- Vol. 3_2021
The role of coronary artery bridging in ischemia and myocardial infarction
- 9 April 2021
- Published by Bionika Media in Therapy
- Vol. 3_2021
The role of coronary artery bridging in ischemia and myocardial infarction
- 19 March 2021
- Published by Bionika Media in Therapy
- Vol. 2_2021
Clinical case: liver damage in thyrotoxicosis
- 19 March 2021
- Published by Bionika Media in Therapy
- Vol. 2_2021
Clinical case: liver damage in thyrotoxicosis
- 1 January 2020
- Published by Izvestia Voronezh State Pedagogical University, Voronezh State Pedagogical University in Культура физическая и здоровье
- No. 2,p. 137-139
BACKWARD WALKING IN REHABILITATION OF PATIENTS WITH JOINT PATHOLOGY (REVIEW)
- 1 January 2020
- Published by Izvestia Voronezh State Pedagogical University, Voronezh State Pedagogical University in Культура физическая и здоровье
- No. 2,p. 137-139
BACKWARD WALKING IN REHABILITATION OF PATIENTS WITH JOINT PATHOLOGY (REVIEW)